<VariationArchive VariationID="1696064" VariationName="NM_000123.4(ERCC5):c.1975del (p.Ser659fs)" VariationType="Deletion" Accession="VCV001696064" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-01-26" DateCreated="2016-08-22" MostRecentSubmission="2022-09-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1688473" VariationID="1696064">
      <GeneList>
        <Gene Symbol="BIVM-ERCC5" FullName="BIVM-ERCC5 readthrough" GeneID="100533467" HGNC_ID="HGNC:43690" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>13q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102807146" stop="102875995" display_start="102807146" display_stop="102875995" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103459495" stop="103528350" display_start="103459495" display_stop="103528350" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="ERCC5" FullName="ERCC excision repair 5, endonuclease" GeneID="2073" HGNC_ID="HGNC:3437" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>13q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102846032" stop="102875995" display_start="102846032" display_stop="102875995" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103498190" stop="103528350" display_start="103498190" display_stop="103528350" Strand="+" />
          </Location>
          <OMIM>133530</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000123.4(ERCC5):c.1975del (p.Ser659fs)</Name>
      <CanonicalSPDI>NC_000013.11:102865684:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102865685" stop="102865685" display_start="102865685" display_stop="102865685" variantLength="1" positionVCF="102865684" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103518035" stop="103518035" display_start="103518035" display_stop="103518035" variantLength="1" positionVCF="103518034" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S1113fs</ProteinChange>
      <ProteinChange>S659fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_464" sequenceAccession="LRG_464">
            <Expression>LRG_464:g.24864del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_464t1" sequenceAccession="LRG_464t1">
            <Expression>LRG_464t1:c.1975del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.103518037del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.103518037del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.102865687del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.102865687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007146.1" sequenceAccession="NG_007146" sequenceVersion="1" change="g.24864del">
            <Expression>NG_007146.1:g.24864del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204425.2" sequenceAccession="NM_001204425" sequenceVersion="2" change="c.3337del">
            <Expression>NM_001204425.2:c.3337del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001191354.2" sequenceAccession="NP_001191354" sequenceVersion="2" change="p.Ser1113fs">
            <Expression>NP_001191354.2:p.Ser1113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000123.4" sequenceAccession="NM_000123" sequenceVersion="4" change="c.1975del" MANESelect="true">
            <Expression>NM_000123.4:c.1975del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000114.3" sequenceAccession="NP_000114" sequenceVersion="3" change="p.Ser659fs">
            <Expression>NP_000114.3:p.Ser659fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000123.3" sequenceAccession="NM_000123" sequenceVersion="3" change="c.1975del">
            <Expression>NM_000123.3:c.1975del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="133530.0004" DB="OMIM" />
        <XRef Type="rs" ID="1882806435" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000123.4(ERCC5):c.1975del (p.Ser659fs) AND Xeroderma pigmentosum group G/Cockayne syndrome" Accession="RCV002266207" Version="2">
        <ClassifiedConditionList TraitSetID="5437">
          <ClassifiedCondition DB="MedGen" ID="C1968561">Xeroderma pigmentosum group G/Cockayne syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000123.4(ERCC5):c.1975del (p.Ser659fs) AND Xeroderma pigmentosum" Accession="RCV002266208" Version="1">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-08-22" MostRecentSubmission="2022-09-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2478446</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30838033</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8317483</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9096355</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5437" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8975" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME</ElementValue>
                <XRef ID="278780" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum group G/Cockayne syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XPG/CS</ElementValue>
                <XRef ID="278780" DB="OMIM" />
              </Symbol>
              <XRef ID="C1968561" DB="MedGen" />
              <XRef ID="MONDO:0800314" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4986985" SubmissionDate="2022-07-15" DateLastUpdated="2022-07-18" DateCreated="2022-07-18">
        <ClinVarSubmissionID localKey="NM_000123.3:c.1975delA|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002547789" DateUpdated="2022-07-18" DateCreated="2022-07-18" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30838033</ID>
          </Citation>
          <Comment>Variant summary: ERCC5 c.1975delA (p.Ser659ValfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 250700 control chromosomes. c.1975delA has been reported in the literature in individuals affected with Xeroderma Pigmentosum (example, Nouspikel_1997 cited in Chikhaoui_2019). These data indicate that the variant may be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000123.3:c.1975delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11800792</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="38316" SubmissionDate="2020-03-19" DateLastUpdated="2022-09-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="133530.0004_XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME" title="ERCC5, 1-BP DEL, 2170A_XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME" />
        <ClinVarAccession Accession="SCV000038316" DateUpdated="2022-09-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Flemish girl with XPG/Cockayne syndrome (see 278780), Nouspikel et al. (1997) identified a homozygous 1-bp deletion within an AAA triplet at nucleotides 2170-2172, which resulted in a TGA stop codon after amino acid 659. Such a deletion was considered characteristic of a slippage error during DNA replication. The patient had psychomotor retardation, microcephaly, and was severely sunlight-sensitive with several pigmented cutaneous spots (Jaeken et al., 1989; Vermeulen et al., 1993). She died at 6.5 years of age.</Attribute>
              <Citation>
                <ID Source="PubMed">9096355</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2478446</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8317483</ID>
              </Citation>
              <XRef DB="OMIM" ID="278780" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <Name>ERCC5, 1-BP DEL, 2170A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2170A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="133530.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4986985" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38316" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1968561" Name="Xeroderma pigmentosum group G/Cockayne syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

